Mumbai
Tier 1
$7,000 - $36,000
Advanced thoracic surgery, radiation, and immunotherapy can push costs higher.
Thoracic oncology cost
Lung cancer treatment cost in India by stage and biomarker plan
Plan lung cancer care with city-wise USD ranges, biopsy and mutation testing guidance, surgery or radiation planning, chemotherapy, targeted therapy, and immunotherapy cost drivers.
How much does lung cancer treatment cost in India?
Lung cancer treatment in India commonly ranges from $5,000 to $36,000 or more depending on stage, biopsy method, mutation testing, surgery, radiation, chemotherapy, targeted therapy, immunotherapy, and ICU needs. Molecular testing is especially important because EGFR, ALK, ROS1, PD-L1, and other results can change both treatment and cost.
City-wise cost
USD range by Indian city
These ranges are planning bands. A hospital-backed quote should be requested after reports, diagnosis, and fitness details are reviewed.
City Tier USD range Planning note
Delhi NCR
Tier 1
$6,800 - $35,000
Useful for molecular testing, thoracic tumor board, and high-cost drug planning.
Gurugram
Tier 1
$7,000 - $36,000
Often selected for premium oncology infrastructure and international coordination.
Bangalore
Tier 1
$6,500 - $33,000
Strong for diagnostics, thoracic oncology, radiation, and targeted therapy review.
Chennai
Tier 1
$6,200 - $32,000
Established option for multi-modality lung cancer treatment.
Hyderabad
Tier 1
$6,000 - $31,000
Can offer comprehensive care with efficient package planning.
Pune
Major metro
$5,600 - $28,000
Useful for selected surgery, chemo, and radiation plans.
Ahmedabad
Major metro
$5,500 - $27,000
Competitive for planned thoracic oncology care when biomarkers are clear.
Kolkata
Major metro
$5,300 - $26,000
Can work for eastern-region patients comparing lung cancer teams.
Indore
Tier 2
$5,000 - $23,000
Best for stable phases after confirming pulmonology, oncology, and emergency support.
Bhopal
Tier 2
$5,000 - $22,500
May reduce total stay cost for selected chemo or follow-up care.
Vizag
Tier 2
$5,200 - $24,000
Confirm radiation access, biopsy support, and ICU backup before choosing.
Tier choice
When Tier 1 or Tier 2 cities may make sense
Tier 1 for advanced or mutation-led care
Complex stage IV disease, immunotherapy, targeted therapy, SBRT, or thoracic surgery may need Tier 1 depth.
Tier 2 for stable cycles
Selected chemotherapy, follow-up scans, or stable radiation plans can work in Tier 2 cities if emergency support is strong.
Check oxygen and ICU support
Breathing issues can escalate quickly, so hospital backup matters more than the lowest estimate.
Included
What the estimate usually covers
Treatment phase
Quoted surgery, chemotherapy, radiation, targeted therapy, or immunotherapy phase.
Each phase needs separate pricing.
Oncology consults
Medical, surgical, radiation oncology, pulmonology, or thoracic surgery review as needed.
Tumor board review is valuable.
Admission or day care
Room, day-care chemotherapy, nursing, and routine monitoring for the quoted phase.
Treatment may be spread across cycles.
Routine medicines
Standard supportive medicines during admission or day care.
High-cost drugs must be named.
Not included
What patients should confirm separately
Molecular testing
EGFR, ALK, ROS1, BRAF, MET, RET, NTRK, PD-L1, or broad NGS panels.
These tests can decide therapy.
High-cost drugs
Immunotherapy, targeted tablets, imported medicines, or maintenance therapy.
Drug names and cycles should be listed.
Respiratory complications
Pleural fluid drainage, oxygen support, ICU, infection care, or ventilation.
Lung patients can need urgent support.
Repeated scans
PET CT, CT chest, brain MRI, or response assessment scans across treatment.
Not always bundled.
Cost drivers
Factors that can change the final estimate
Stage and spread
Localized disease may need surgery or radiation, while advanced disease often needs systemic therapy.
PET CT is central.
Biomarker result
Mutation-positive disease may need targeted medicines; PD-L1 status can affect immunotherapy.
Testing changes cost.
Surgery complexity
Lobectomy, pneumonectomy, VATS, robotic surgery, or open surgery have different costs.
Pulmonary fitness matters.
Radiation plan
SBRT, IMRT, conventional radiation, or palliative radiation vary by session count and planning.
Technique matters.
Supportive care
Oxygen, infection control, nutrition, blood support, and pleural procedures can add cost.
Common in advanced disease.
Reports
Reports needed for a more accurate quote
The report checklist is different for each treatment so every cost page avoids generic duplicated content.
Lung cancer reports
Lung cancer planning depends on pathology, stage, breathing fitness, and molecular markers.
Biopsy and IHC
Confirms cancer type and subtype, including adenocarcinoma, squamous, or small-cell patterns.
Molecular and PD-L1 reports
Mutation and immunotherapy markers influence drug selection and long-term cost.
PET CT and CT chest
Shows spread in lung, lymph nodes, bones, liver, adrenal glands, and other areas.
Pulmonary and fitness records
PFT, oxygen level, smoking history, and performance status help decide surgery or radiation safety.
Hospital selection
How to compare hospitals beyond the lowest package
Thoracic tumor board
Confirm medical oncology, radiation oncology, pulmonology, thoracic surgery, radiology, and pathology input.
Needed for sequencing.
Molecular testing pathway
Ask how tissue is handled, which markers are tested, and whether NGS is recommended.
Avoid starting therapy blindly.
Radiation capability
Check SBRT, IMRT, planning timelines, and palliative radiation access.
Important in lung tumors.
Emergency respiratory support
Confirm oxygen, ICU, pleural procedure support, infection care, and pulmonology availability.
Critical for breathless patients.
Patient journey
From first estimate to treatment travel
Biopsy confirmation
The team confirms lung cancer subtype and whether more tissue or repeat testing is needed.
Mutation-led planning
Biomarker results guide targeted therapy, immunotherapy, chemotherapy, or combined treatment.
City capability match
Hospital choice depends on thoracic surgery, radiation, ICU, pulmonology, and drug access.
Response tracking
Scans and symptom review decide whether treatment continues, changes, or shifts to maintenance.
Recovery planning
Stay, follow-up, and return-home planning
After lung surgery
Chest tube care, breathing exercises, pain control, and pulmonary rehab guidance should be clear.
During systemic therapy
Fever, breathlessness, cough, low counts, and drug side effects need a written action plan.
Home-country handoff
Mutation reports, drug names, cycle dates, scans, and response assessment should be shared with the local oncologist.
Questions
Common questions
Why is molecular testing important for lung cancer cost?
Molecular results can shift treatment from chemotherapy to targeted tablets or immunotherapy, which changes both cost and treatment duration.
Can lung cancer surgery be done in Tier 2 cities?
Selected cases may be possible, but thoracic surgery, ICU, pulmonology, and emergency support must be confirmed carefully.
What reports are needed for a lung cancer quote?
Biopsy, IHC, molecular markers, PD-L1, PET CT, CT chest, brain MRI if done, and lung-function records are useful.
Is immunotherapy included in lung cancer estimates?
Only if the quote names the immunotherapy drug, dose, cycle count, and monitoring plan. It is often a separate high-cost item.
How long does lung cancer treatment take?
Surgery may be one admission, radiation can take days to weeks, and chemotherapy or immunotherapy may continue for multiple cycles.
Can chemotherapy be done in one city and follow-up at home?
Sometimes yes, if the protocol, drug availability, scan schedule, and local oncologist handoff are clear.
When should a patient avoid the cheapest lung cancer quote?
Avoid low quotes that skip biomarker testing, tumor board review, respiratory backup, or clear drug-cycle details.
Can Virello compare lung cancer hospitals?
Yes. Virello can compare tumor board depth, molecular testing, drug access, radiation capability, ICU support, and city cost.